{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:06:06Z","timestamp":1762985166091,"version":"3.45.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jdin.2022.01.009","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T22:29:27Z","timestamp":1644359367000},"page":"164-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Pityriasis rosea\u2013like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature"],"prefix":"10.1016","volume":"7","author":[{"given":"Jordan E.","family":"Buckley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura N.","family":"Landis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P.","family":"Rapini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Ritchie","key":"10.1016\/j.jdin.2022.01.009_bib2"},{"issue":"1","key":"10.1016\/j.jdin.2022.01.009_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2022.01.009_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.0022-202X.2005.23719.x","article-title":"Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7","volume":"124","author":"Broccolo","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2022.01.009_bib4","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1111\/jdv.17301","article-title":"Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance","volume":"35","author":"Busto-Leis","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jdin.2022.01.009_bib5","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/bjd.20143","article-title":"Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination","volume":"185","author":"Carballido V\u00e1zquez","year":"2021","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2022.01.009_bib6","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1080\/21645515.2021.1963173","article-title":"Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine","volume":"17","author":"Cohen","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.jdin.2022.01.009_bib7","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1111\/jdv.17342","article-title":"Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 vaccine","volume":"35","author":"Cyrenne","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jdin.2022.01.009_bib8","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1111\/jdv.17498","article-title":"Pityriasis rosea developing after COVID-19 vaccination","volume":"35","author":"Marcantonio-Santa Cruz","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.jdin.2022.01.009_bib9","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1111\/jocd.14372","article-title":"Pityriasis rosea following SARS-CoV-2 vaccination: a case series","volume":"20","author":"Temiz","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2022.01.009_bib10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/ijd.15700","article-title":"Pityriasis rosea after mRNA COVID-19 vaccination","volume":"60","author":"Abdullah","year":"2021","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2022.01.009_bib11","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1111\/jdv.17343","article-title":"Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy","volume":"35","author":"Farinazzo","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.009_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000445375","article-title":"Pityriasis rosea: a comprehensive classification","volume":"232","author":"Drago","year":"2016","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.jdin.2022.01.009_bib13","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1111\/jdv.16579","article-title":"Pityriasis rosea as a cutaneous manifestation of COVID-19 infection","volume":"34","author":"Ehsani","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.009_bib14","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/jmv.26549","article-title":"Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19","volume":"93","author":"Drago","year":"2021","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.009_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdv.12942","article-title":"Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature","volume":"30","author":"Drago","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"27","key":"10.1016\/j.jdin.2022.01.009_bib16","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jdin.2022.01.009_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:00:31Z","timestamp":1762981231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328722000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":17,"alternative-id":["S2666328722000141"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2022.01.009","relation":{},"ISSN":["2666-3287"],"issn-type":[{"type":"print","value":"2666-3287"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pityriasis rosea\u2013like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2022.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}